25 XP   0   0   10

Tenax Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Tenax Therapeutics Inc together

I guess you are interested in Tenax Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tenax Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Tenax Therapeutics Inc

I send you an email if I find something interesting about Tenax Therapeutics Inc.

Quick analysis of Tenax Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Tenax Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.4%

What is your share worth?

Current worth
$6.35
Expected worth in 1 year
$5.40
How sure are you?
22.0%

+ What do you gain per year?

Total Gains per Share
$-0.94
Return On Investment
-29.7%

For what price can you sell your share?

Current Price per Share
$3.18
Expected price per share
$2.77 - $3.6
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Tenax Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$3.18

Intrinsic Value Per Share

$-85.60 - $-61.04

Total Value Per Share

$-79.25 - $-54.69

2. Growth of Tenax Therapeutics Inc (5 min.)




Is Tenax Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$12.4m$6.6m$4.6m41.1%

How much money is Tenax Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$626.2k-$6m$5.4m867.3%
Net Profit Margin-13,927.5%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Tenax Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#618 / 966

Most Revenue
#779 / 966

Most Profit
#202 / 966

Most Efficient
#904 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Tenax Therapeutics Inc? (5 min.)

Welcome investor! Tenax Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Tenax Therapeutics Inc.

What can you expect buying and holding a share of Tenax Therapeutics Inc?

First you should know what it really means to hold a share of Tenax Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Tenax Therapeutics Inc is $3.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tenax Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tenax Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $6.35. Based on the TTM, the Book Value Change Per Share is $-0.24 per quarter. Based on the YOY, the Book Value Change Per Share is $1.62 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tenax Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.9461.0%-0.32-10.1%-1.62-50.9%-0.24-7.7%0.4714.8%
Usd Book Value Change Per Share2.2169.6%-0.24-7.4%1.6250.9%0.020.5%-0.22-7.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.2169.6%-0.24-7.4%1.6250.9%0.020.5%-0.22-7.0%
Usd Price Per Share4.24-1.28-0.26-1.13-1.99-
Price to Earnings Ratio0.55-0.07--0.04-0.04-0.18-
Price-to-Total Gains Ratio1.92-0.22--0.01--0.80--1.18-
Price to Book Ratio0.67-0.21-0.10-0.53-33.44-
Price-to-Total Gains Ratio1.92-0.22--0.01--0.80--1.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.18
Number of shares314
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.240.02
Usd Total Gains Per Share-0.240.02
Gains per Quarter (314 shares)-74.075.28
Gains per Year (314 shares)-296.2921.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-296-30602111
20-593-60204232
30-889-89806353
40-1185-119408474
50-1482-1490010695
60-1778-17860127116
70-2074-20820148137
80-2371-23780169158
90-2667-26740190179
100-2963-29700211200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%19.022.00.046.3%28.084.00.025.0%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%5.015.00.025.0%9.030.02.022.0%28.064.020.025.0%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.019.05.0%1.00.040.02.4%2.00.0110.01.8%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%5.015.00.025.0%9.030.02.022.0%29.063.020.025.9%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Tenax Therapeutics Inc

About Tenax Therapeutics Inc

Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension in the United States. The company develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.

Fundamental data was last updated by Penke on 2024-06-19 08:39:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Tenax Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tenax Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Tenax Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tenax Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-13,927.5%+13,927.5%
TTM-13,927.5%YOY--13,927.5%
TTM-13,927.5%5Y-2,785.5%-11,142.0%
5Y-2,785.5%10Y-648.9%-2,136.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--168.0%+168.0%
TTM-13,927.5%-209.9%-13,717.6%
YOY--242.3%+242.3%
5Y-2,785.5%-401.7%-2,383.8%
10Y-648.9%-532.2%-116.7%
1.1.2. Return on Assets

Shows how efficient Tenax Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tenax Therapeutics Inc to the Biotechnology industry mean.
  • 26.3% Return on Assets means that Tenax Therapeutics Inc generated $0.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tenax Therapeutics Inc:

  • The MRQ is 26.3%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is -6.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ26.3%TTM-6.4%+32.7%
TTM-6.4%YOY-97.7%+91.2%
TTM-6.4%5Y-77.6%+71.2%
5Y-77.6%10Y-49.6%-28.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ26.3%-11.9%+38.2%
TTM-6.4%-11.9%+5.5%
YOY-97.7%-11.3%-86.4%
5Y-77.6%-13.5%-64.1%
10Y-49.6%-14.9%-34.7%
1.1.3. Return on Equity

Shows how efficient Tenax Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tenax Therapeutics Inc to the Biotechnology industry mean.
  • 30.6% Return on Equity means Tenax Therapeutics Inc generated $0.31 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tenax Therapeutics Inc:

  • The MRQ is 30.6%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is -8.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ30.6%TTM-8.8%+39.3%
TTM-8.8%YOY-137.2%+128.4%
TTM-8.8%5Y-123.6%+114.8%
5Y-123.6%10Y-75.2%-48.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ30.6%-14.2%+44.8%
TTM-8.8%-15.7%+6.9%
YOY-137.2%-14.3%-122.9%
5Y-123.6%-19.2%-104.4%
10Y-75.2%-19.7%-55.5%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Tenax Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tenax Therapeutics Inc is operating .

  • Measures how much profit Tenax Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tenax Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tenax Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-14,425.5%+14,425.5%
TTM-14,425.5%YOY--14,425.5%
TTM-14,425.5%5Y-2,885.1%-11,540.4%
5Y-2,885.1%10Y2,287.2%-5,172.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--354.6%+354.6%
TTM-14,425.5%-225.9%-14,199.6%
YOY--252.2%+252.2%
5Y-2,885.1%-428.3%-2,456.8%
10Y2,287.2%-531.1%+2,818.3%
1.2.2. Operating Ratio

Measures how efficient Tenax Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Tenax Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM144.255-144.255
TTM144.255YOY-+144.255
TTM144.2555Y28.851+115.404
5Y28.85110Y-19.428+48.279
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.004-3.004
TTM144.2553.332+140.923
YOY-3.502-3.502
5Y28.8515.271+23.580
10Y-19.4286.915-26.343
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Tenax Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tenax Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.12 means the company has $7.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Tenax Therapeutics Inc:

  • The MRQ is 7.121. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.788. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.121TTM11.788-4.667
TTM11.788YOY7.350+4.438
TTM11.7885Y6.333+5.455
5Y6.33310Y6.322+0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1213.767+3.354
TTM11.7884.000+7.788
YOY7.3504.905+2.445
5Y6.3335.883+0.450
10Y6.3226.286+0.036
1.3.2. Quick Ratio

Measures if Tenax Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tenax Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 6.18 means the company can pay off $6.18 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tenax Therapeutics Inc:

  • The MRQ is 6.180. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.917. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.180TTM10.917-4.737
TTM10.917YOY6.580+4.337
TTM10.9175Y5.988+4.929
5Y5.98810Y7.432-1.444
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1803.054+3.126
TTM10.9173.506+7.411
YOY6.5804.756+1.824
5Y5.9885.757+0.231
10Y7.4326.338+1.094
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Tenax Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tenax Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tenax Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Tenax Therapeutics Inc assets are financed with 14.0% credit (debt) and the remaining percentage (100% - 14.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tenax Therapeutics Inc:

  • The MRQ is 0.140. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.139. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.140TTM0.139+0.001
TTM0.139YOY0.245-0.106
TTM0.1395Y0.272-0.133
5Y0.27210Y0.210+0.061
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1400.330-0.190
TTM0.1390.342-0.203
YOY0.2450.287-0.042
5Y0.2720.368-0.096
10Y0.2100.382-0.172
1.4.2. Debt to Equity Ratio

Measures if Tenax Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tenax Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 16.3% means that company has $0.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tenax Therapeutics Inc:

  • The MRQ is 0.163. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.180. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.163TTM0.180-0.017
TTM0.180YOY0.445-0.265
TTM0.1805Y0.456-0.275
5Y0.45610Y0.318+0.138
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1630.365-0.202
TTM0.1800.415-0.235
YOY0.4450.370+0.075
5Y0.4560.443+0.013
10Y0.3180.476-0.158
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Tenax Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Tenax Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Tenax Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of 0.55 means the investor is paying $0.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tenax Therapeutics Inc:

  • The EOD is 0.410. Based on the earnings, the company is cheap. +2
  • The MRQ is 0.546. Based on the earnings, the company is cheap. +2
  • The TTM is 0.074. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.410MRQ0.546-0.137
MRQ0.546TTM0.074+0.472
TTM0.074YOY-0.038+0.113
TTM0.0745Y0.038+0.036
5Y0.03810Y0.180-0.142
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.410-2.341+2.751
MRQ0.546-2.997+3.543
TTM0.074-2.882+2.956
YOY-0.038-3.553+3.515
5Y0.038-6.262+6.300
10Y0.180-6.288+6.468
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tenax Therapeutics Inc:

  • The EOD is -0.301. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.402. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.186. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.301MRQ-0.402+0.100
MRQ-0.402TTM-0.186-0.215
TTM-0.186YOY-0.056-0.131
TTM-0.1865Y-0.229+0.042
5Y-0.22910Y-113.972+113.743
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.301-2.932+2.631
MRQ-0.402-3.739+3.337
TTM-0.186-3.776+3.590
YOY-0.056-4.917+4.861
5Y-0.229-7.942+7.713
10Y-113.972-8.503-105.469
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tenax Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.67 means the investor is paying $0.67 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Tenax Therapeutics Inc:

  • The EOD is 0.501. Based on the equity, the company is cheap. +2
  • The MRQ is 0.668. Based on the equity, the company is cheap. +2
  • The TTM is 0.208. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.501MRQ0.668-0.167
MRQ0.668TTM0.208+0.460
TTM0.208YOY0.095+0.112
TTM0.2085Y0.532-0.324
5Y0.53210Y33.445-32.913
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5011.843-1.342
MRQ0.6682.249-1.581
TTM0.2082.301-2.093
YOY0.0952.412-2.317
5Y0.5323.782-3.250
10Y33.4454.212+29.233
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Tenax Therapeutics Inc.

3.1. Institutions holding Tenax Therapeutics Inc

Institutions are holding 7.26% of the shares of Tenax Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Qube Research & Technologies0.2250440744070
2024-03-31UBS Group AG0.07070138413840
2024-03-31Tower Research Capital LLC0.02740.00015375370
2024-03-31Atlantic Trust Group, LLC0.017503433430
2024-03-31BlackRock Inc0.015303003000
2024-03-31Morgan Stanley - Brokerage Accounts0.013302602600
2024-03-31Wells Fargo & Co0.00010220
2024-03-31Hanson Mcclain Inc0.00010110
2023-12-31Lido Advisors, LLC000-10000-100
2023-12-31LPL Financial Corp000-20000-100
2023-12-31Honkamp Krueger Financial Services Inc000-10002-100
2023-12-31Virtu Financial LLC000-36799-100
2023-12-31TWO SIGMA SECURITIES, LLC000-97037-100
Total 0.36940.00017234-166604-2,303.1%

3.2. Funds holding Tenax Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr0.11880232600
2024-04-30Fidelity Extended Market Index0.07420145300
2024-04-30Fidelity Nasdaq Composite Index0.0196038400
2023-12-31NT US Market Cap Idx Fd - L0.0001013600
2024-03-31NT Ext Equity Mkt Idx Fd - NL0.000601200
2024-05-31State St US Extended Mkt Indx NL Cl C0.000601100
2024-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.000501000
2024-03-31Northern Trust Extended Eq Market Idx0.00050990
2024-03-31NT Ext Equity Mkt Idx Fd - L0.000509112.5
2024-03-31Northern Trust Wilshire 50000.00010220
Total 0.215504352+12+0.3%

3.3. Insider Transactions

Insiders are holding 0.355% of the shares of Tenax Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2020-09-08Armistice Capital, LlcBUY85431.46
2020-09-04Armistice Capital, LlcBUY234571.41
2020-09-02Armistice Capital, LlcBUY200001.47
2020-08-31Armistice Capital, LlcBUY200001.45
2020-08-27Armistice Capital, LlcBUY120001.5
2020-08-26Armistice Capital Master FundBUY349031.51
2020-08-24Armistice Capital, LlcBUY56921.47
2020-08-21Armistice Capital, LlcBUY1162421.44
2020-08-19Armistice Capital, LlcBUY707671.45
2020-05-18Ronald R BlanckBUY50001.09 
2017-12-18Ronald R BlanckBUY129500.4513624
2017-11-14Ronald R BlanckSELL129500.397149
2016-11-23Gerald T ProehlBUY298821.6715433
2015-11-19Ronald R BlanckBUY47003.2612899
2015-01-20Ronald R BlanckBUY20003.49
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Tenax Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.212-0.236+111%1.618+37%0.017+13063%-0.223+110%
Book Value Per Share--6.3475.750+10%3.384+88%3.233+96%10.206-38%
Current Ratio--7.12111.788-40%7.350-3%6.333+12%6.322+13%
Debt To Asset Ratio--0.1400.139+1%0.245-43%0.272-48%0.210-33%
Debt To Equity Ratio--0.1630.180-9%0.445-63%0.456-64%0.318-49%
Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Eps--1.940-0.320+116%-1.618+183%-0.244+113%0.469+313%
Free Cash Flow Per Share---2.638-1.193-55%-1.379-48%-1.242-53%-1.230-53%
Free Cash Flow To Equity Per Share--1.408-0.238+117%1.473-4%0.036+3767%0.582+142%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.017-2%
Intrinsic Value_10Y_max---61.040--------
Intrinsic Value_10Y_min---85.596--------
Intrinsic Value_1Y_max---5.099--------
Intrinsic Value_1Y_min---5.836--------
Intrinsic Value_3Y_max---16.096--------
Intrinsic Value_3Y_min---20.014--------
Intrinsic Value_5Y_max---28.029--------
Intrinsic Value_5Y_min---36.798--------
Market Cap6227203.200-33%8302937.6002503414.016+232%512275.584+1521%2215386.286+275%7756516.221+7%
Net Profit Margin----139.2750%-0%-27.8550%-6.4890%
Operating Margin----144.2550%-0%-28.8510%22.872-100%
Operating Ratio---144.255-100%-0%28.851-100%-19.4280%
Pb Ratio0.501-33%0.6680.208+222%0.095+602%0.532+26%33.445-98%
Pe Ratio0.410-33%0.5460.074+634%-0.038+107%0.038+1339%0.180+203%
Price Per Share3.180-33%4.2401.278+232%0.262+1521%1.131+275%1.991+113%
Price To Free Cash Flow Ratio-0.301+25%-0.402-0.186-54%-0.056-86%-0.229-43%-113.972+28263%
Price To Total Gains Ratio1.438-33%1.9170.222+762%-0.005+100%-0.804+142%-1.180+162%
Quick Ratio--6.18010.917-43%6.580-6%5.988+3%7.432-17%
Return On Assets--0.263-0.064+125%-0.977+472%-0.776+395%-0.496+289%
Return On Equity--0.306-0.088+129%-1.372+549%-1.236+504%-0.752+346%
Total Gains Per Share--2.212-0.236+111%1.618+37%0.017+13059%-0.223+110%
Usd Book Value--12429685.00011259036.250+10%6627026.750+88%6330357.550+96%20549327.424-40%
Usd Book Value Change Per Share--2.212-0.236+111%1.618+37%0.017+13063%-0.223+110%
Usd Book Value Per Share--6.3475.750+10%3.384+88%3.233+96%10.206-38%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Usd Eps--1.940-0.320+116%-1.618+183%-0.244+113%0.469+313%
Usd Free Cash Flow---5165580.000-2335659.500-55%-2700287.500-48%-2432447.750-53%-2495689.083-52%
Usd Free Cash Flow Per Share---2.638-1.193-55%-1.379-48%-1.242-53%-1.230-53%
Usd Free Cash Flow To Equity Per Share--1.408-0.238+117%1.473-4%0.036+3767%0.582+142%
Usd Market Cap6227203.200-33%8302937.6002503414.016+232%512275.584+1521%2215386.286+275%7756516.221+7%
Usd Price Per Share3.180-33%4.2401.278+232%0.262+1521%1.131+275%1.991+113%
Usd Profit--3798840.000-626268.000+116%-6058052.750+259%-4200083.050+211%-4985701.323+231%
Usd Revenue---1447.500-100%-0%289.500-100%2917.237-100%
Usd Total Gains Per Share--2.212-0.236+111%1.618+37%0.017+13059%-0.223+110%
 EOD+3 -5MRQTTM+21 -13YOY+19 -105Y+24 -1010Y+19 -15

4.2. Fundamental Score

Let's check the fundamental score of Tenax Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.410
Price to Book Ratio (EOD)Between0-10.501
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than16.180
Current Ratio (MRQ)Greater than17.121
Debt to Asset Ratio (MRQ)Less than10.140
Debt to Equity Ratio (MRQ)Less than10.163
Return on Equity (MRQ)Greater than0.150.306
Return on Assets (MRQ)Greater than0.050.263
Total8/10 (80.0%)

4.3. Technical Score

Let's check the technical score of Tenax Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.227
Ma 20Greater thanMa 503.186
Ma 50Greater thanMa 1003.434
Ma 100Greater thanMa 2003.732
OpenGreater thanClose3.134
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-03-312023-06-302023-09-302023-12-312024-03-31
Income before Tax  -1,407300-1,106-866-1,972-1,254-3,2267,0243,799
Net Income  -4,3533,247-1,106-866-1,972-1,254-3,2267,0243,799
EBITDA  -1,399302-1,096-869-1,966-1,371-3,3367,1353,799



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets14,460
Total Liabilities2,031
Total Stockholder Equity12,430
 As reported
Total Liabilities 2,031
Total Stockholder Equity+ 12,430
Total Assets = 14,460

Assets

Total Assets14,460
Total Current Assets14,459
Long-term Assets1
Total Current Assets
Cash And Cash Equivalents 12,549
Other Current Assets 1,910
Total Current Assets  (as reported)14,459
Total Current Assets  (calculated)14,459
+/-0
Long-term Assets
Long-term Assets Other 1
Long-term Assets  (as reported)1
Long-term Assets  (calculated)1
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,031
Long-term Liabilities0
Total Stockholder Equity12,430
Total Current Liabilities
Short-term Debt 413
Short Long Term Debt 413
Accounts payable 1,081
Other Current Liabilities 536
Total Current Liabilities  (as reported)2,031
Total Current Liabilities  (calculated)2,444
+/- 413
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock0
Retained Earnings -301,052
Other Stockholders Equity 313,481
Total Stockholder Equity (as reported)12,430
Total Stockholder Equity (calculated)12,430
+/-0
Other
Capital Stock0
Cash and Short Term Investments 12,549
Common Stock Shares Outstanding 1,219
Liabilities and Stockholders Equity 14,460
Net Debt -12,136
Net Invested Capital 12,843
Net Working Capital 12,429
Short Long Term Debt Total 413



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312016-01-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-30
> Total Assets 
630
310
320
320
330
250
250
990
490
490
530
530
500
400
6,200
6,200
5,553
5,212
4,842
4,842
4,225
3,793
3,793
3,276
1,783
1,317
1,317
915
1,166
1,486
1,486
1,048
785
1,809
1,809
1,262
1,467
922
922
611
858
1,598
1,598
1,823
900
2,002
2,002
10,557
10,733
8,395
8,395
3,803
8,241
5,028
5,028
3,529
3,094
2,853
2,853
2,922
4,549
5,890
5,890
4,142
3,542
3,043
3,181
5,889
4,362
33,936
33,936
93,429
89,222
86,193
82,908
82,908
75,454
73
23,340
69,540
64,134
59,712
23,340
19,155
13,449
11,003
9,891
9,891
7,026
5,454
13,337
13,337
9,664
7,774
6,365
5,955
5,353
8,997
6,869
4,561
2,885
8,912
5,992
3,738
8,355
4,739
3,405
15,272
14,045
11,889
11,685
14,460
14,46011,68511,88914,04515,2723,4054,7398,3553,7385,9928,9122,8854,5616,8698,9975,3535,9556,3657,7749,66413,33713,3375,4547,0269,8919,89111,00313,44919,15523,34059,71264,13469,54023,3407375,45482,90882,90886,19389,22293,42933,93633,9364,3625,8893,1813,0433,5424,1425,8905,8904,5492,9222,8532,8533,0943,5295,0285,0288,2413,8038,3958,39510,73310,5572,0022,0029001,8231,5981,5988586119229221,4671,2621,8091,8097851,0481,4861,4861,1669151,3171,3171,7833,2763,7933,7934,2254,8424,8425,2125,5536,2006,200400500530530490490990250250330320320310630
   > Total Current Assets 
350
30
70
70
110
30
30
760
270
270
250
250
200
100
5,937
5,937
5,143
4,794
4,364
4,364
3,584
3,132
3,132
2,532
1,058
627
627
251
542
830
830
421
131
1,158
1,158
666
785
292
292
155
459
1,228
1,228
1,483
446
1,191
1,191
4,953
5,223
4,280
4,280
2,745
6,965
3,640
3,640
2,185
1,612
1,316
1,316
1,632
2,874
4,333
4,333
2,631
2,117
1,652
1,842
4,587
3,094
7,389
7,389
58,966
23,008
17,669
17,511
17,511
21,864
21
13,628
16,100
10,175
7,667
13,628
12,788
8,997
8,663
8,063
8,063
6,710
5,141
13,320
13,320
9,425
7,562
6,181
5,798
5,214
8,897
6,796
4,518
2,532
8,583
5,689
3,456
8,102
4,514
3,208
15,265
14,039
11,883
11,684
14,459
14,45911,68411,88314,03915,2653,2084,5148,1023,4565,6898,5832,5324,5186,7968,8975,2145,7986,1817,5629,42513,32013,3205,1416,7108,0638,0638,6638,99712,78813,6287,66710,17516,10013,6282121,86417,51117,51117,66923,00858,9667,3897,3893,0944,5871,8421,6522,1172,6314,3334,3332,8741,6321,3161,3161,6122,1853,6403,6406,9652,7454,2804,2805,2234,9531,1911,1914461,4831,2281,2284591552922927856661,1581,1581314218308305422516276271,0582,5323,1323,1323,5844,3644,3644,7945,1435,9375,9371002002502502702707603030110707030350
       Cash And Cash Equivalents 
140
10
50
50
100
100
740
740
250
170
190
190
200
40
5,466
5,466
5,099
4,694
4,251
4,251
3,497
2,908
2,908
2,442
1,035
524
524
178
473
723
723
302
110
1,051
1,051
589
712
153
153
0
102
22
22
16
1
940
940
4,881
5,205
4,146
4,146
2,556
975
2,876
2,876
633
837
522
522
952
2,004
3,282
3,282
1,880
1,512
829
784
4,073
2,543
6,340
6,340
58,321
14,356
9,915
7,926
7,926
5,099
4
9,996
3,263
1,928
722
9,996
7,028
2,234
1,764
1,605
1,605
3,903
3,347
12,367
12,367
8,407
6,649
4,906
4,359
4,085
8,236
6,250
3,537
1,671
8,354
5,584
2,869
7,229
3,806
2,124
14,415
13,394
11,141
9,792
12,549
12,5499,79211,14113,39414,4152,1243,8067,2292,8695,5848,3541,6713,5376,2508,2364,0854,3594,9066,6498,40712,36712,3673,3473,9031,6051,6051,7642,2347,0289,9967221,9283,2639,99645,0997,9267,9269,91514,35658,3216,3406,3402,5434,0737848291,5121,8803,2823,2822,0049525225228376332,8762,8769752,5564,1464,1465,2054,881940940116222210201531537125891,0511,0511103027237234731785245241,0352,4422,9082,9083,4974,2514,2514,6945,0995,4665,46640200190190170250740740100100505010140
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,166
8,226
7,159
9,200
9,200
16,585
17
3,285
12,511
8,024
6,756
3,285
5,495
6,563
6,771
6,122
6,122
2,504
1,509
495
495
502
479
494
499
468
473
463
495
511
0
0
0
0
0
0
0
0
0
0
0
000000000005114954634734684994944795024954951,5092,5046,1226,1226,7716,5635,4953,2856,7568,02412,5113,2851716,5859,2009,2007,1598,2264,16600000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
200
200
0
0
0
0
0
0
0
0
0
0
0
400
400
400
0
30
30
30
30
30
30
30
30
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
32
32
5,474
159
159
72
22
8
8
139
383
167
167
49
59
101
541
121
124
166
166
66
36
65
76
76
86
0
73
49
25
73
73
25
25
25
50
50
39
0
0
0
0
0
0
0
0
0
0
0
8
0
0
0
0
0
0
0
0
0
0
0
000000000008000000000003950502525257373254973086767665366616616612412154110159491671673831398822721591595,4743232320000000000000000000000003030303030303030040040040000000000000200200
       Other Current Assets 
10
20
20
20
10
30
0
20
20
100
0
60
0
60
71
71
43
100
0
83
58
194
90
90
23
103
73
73
69
107
119
119
21
107
77
78
73
140
155
78
343
1,113
1,467
1,404
438
132
72
72
18
134
157
157
224
195
945
695
81
37
284
8
283
206
619
163
145
273
170
170
109
136
579
177
35
18
279
29
93
0
275
277
199
116
275
239
176
104
286
286
263
285
458
458
516
434
781
941
661
189
83
486
350
229
105
587
872
707
346
305
283
267
1,891
1,910
1,9101,89126728330534670787258710522935048683189661941781434516458458285263286286104176239275116199277275093292791835177579136109170170273145163619206283828437816959451952241571571341872721324381,4041,4671,11334378155140737877107211191191076973731032390901945883010043717160060010020200301020202010
   > Long-term Assets 
280
280
250
250
220
220
220
230
220
220
280
280
300
300
262
262
410
417
478
478
641
660
660
744
725
690
690
664
624
656
656
627
654
652
652
596
682
630
630
456
400
370
370
339
454
811
811
5,604
5,511
4,115
4,115
1,058
1,276
1,389
1,389
1,344
1,482
1,537
1,537
1,290
1,675
1,557
1,557
1,511
1,425
1,391
1,338
1,302
1,268
26,547
26,547
34,463
66,215
68,523
65,397
65,397
53,591
52
9,712
53,441
53,959
52,045
9,712
6,367
4,452
2,340
1,828
1,828
316
313
17
17
239
212
184
156
139
99
73
43
353
328
303
282
254
225
196
7
7
6
1
1
1167719622525428230332835343739913915618421223917173133161,8281,8282,3404,4526,3679,71252,04553,95953,4419,7125253,59165,39765,39768,52366,21534,46326,54726,5471,2681,3021,3381,3911,4251,5111,5571,5571,6751,2901,5371,5371,4821,3441,3891,3891,2761,0584,1154,1155,5115,604811811454339370370400456630630682596652652654627656656624664690690725744660660641478478417410262262300300280280220220230220220220250250280280
       Property Plant Equipment 
190
170
140
140
110
100
100
90
70
70
60
60
-300
-300
32
32
180
188
244
244
402
422
485
486
473
445
426
426
397
437
407
407
440
431
384
384
350
333
298
298
246
220
194
194
178
148
178
178
169
213
210
210
242
328
384
384
440
440
443
443
351
317
294
294
248
227
205
183
160
149
124
124
82
67
50
50
42
0
19
34
29
24
19
18
15
13
10
10
10
8
9
9
231
204
176
148
120
91
65
35
345
320
295
274
246
217
187
6
6
5
0
0
005661872172462742953203453565911201481762042319981010101315181924293419042505067821241241491601832052272482942943173514434434404403843843282422102102131691781781481781941942202462982983333503843844314404074074373974264264454734864854224022442441881803232-300-3006060707090100100110140140170190
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,303
3,303
11,265
11,265
11,265
11,265
11,265
11,265
11
0
11,265
11,265
11,265
11,265
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000011,26511,26511,26511,26501111,26511,26511,26511,26511,26511,2653,3033,303000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,320
30,681
32,996
30,975
22,561
19,177
18,019
8,586
19,035
19,558
17,649
8,586
5,242
3,330
2,324
1,809
1,300
297
296
0
0
0
0
0
0
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000110000002962971,3001,8092,3243,3305,2428,58617,64919,55819,0358,58618,01919,17722,56130,97532,99630,68130,32000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
90
110
110
110
110
120
120
140
150
160
220
220
0
0
230
230
231
230
234
234
239
238
238
259
252
245
245
238
227
220
220
219
214
221
221
212
177
156
156
158
154
150
150
145
137
134
134
129
445
536
536
650
801
824
824
908
919
968
968
700
831
864
864
873
904
923
925
943
964
22,983
22,983
23,000
23,030
23,038
22,000
22,000
22,000
22
0
22,000
22,000
22,000
22,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000022,00022,00022,00022,00002222,00022,00022,00023,03823,03023,00022,98322,9839649439259239048738648648317009689689199088248248016505365364451291341341371451501501541581561561772122212212142192202202272382452452522592382382392342342302312302300022022016015014012012011011011011090
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
245
239
238
259
256
252
245
238
232
227
220
220
219
214
221
212
381
332
297
158
156
154
150
146
215
276
663
5,426
5,558
5,341
3,902
848
946
1,035
1,060
960
1,008
1,042
1,097
847
1,283
1,324
1,240
1,217
0
0
0
1,134
0
0
0
34,339
64,636
66,132
68,456
65,347
56,934
53,548
0
0
0
53,930
52,021
9,693
6,349
4,437
2,327
1,818
0
0
8
8
8
8
8
8
8
8
8
8
8
0
8
8
8
8
0
0
0
0
0
0
0
00000008888088888888888001,8182,3274,4376,3499,69352,02153,93000053,54856,93465,34768,45666,13264,63634,3390001,1340001,2171,2401,3241,2838471,0971,0421,0089601,0601,0359468483,9025,3415,5585,4266632762151461501541561582973323812122212142192202202272322382452522562592382392450000000000000000000
> Total Liabilities 
390
600
600
600
680
700
700
630
550
620
630
630
600
600
345
345
297
295
344
344
349
398
398
179
113
82
82
15
52
334
334
294
420
362
362
314
231
329
329
425
1,120
1,581
1,581
1,846
2,598
2,460
2,460
805
1,746
1,792
1,792
701
1,652
1,199
1,199
1,402
1,466
3,746
3,746
6,647
8,274
6,762
6,762
4,488
3,600
4,643
4,959
4,759
1,509
3,635
3,635
10,544
11,635
10,829
12,479
12,479
11,525
5
6,199
14,207
13,240
13,019
6,199
5,041
2,183
839
1,009
1,009
793
516
1,566
1,566
1,044
1,237
2,593
2,536
2,324
1,593
2,243
1,465
1,414
1,673
1,748
2,131
1,572
785
1,912
994
824
602
3,587
2,031
2,0313,5876028249941,9127851,5722,1311,7481,6731,4141,4652,2431,5932,3242,5362,5931,2371,0441,5661,5665167931,0091,0098392,1835,0416,19913,01913,24014,2076,199511,52512,47912,47910,82911,63510,5443,6353,6351,5094,7594,9594,6433,6004,4886,7626,7628,2746,6473,7463,7461,4661,4021,1991,1991,6527011,7921,7921,7468052,4602,4602,5981,8461,5811,5811,12042532932923131436236242029433433452158282113179398398349344344295297345345600600630630620550630700700680600600600390
   > Total Current Liabilities 
380
590
600
600
680
700
700
530
500
570
580
580
500
500
345
345
297
295
344
344
349
398
398
179
113
82
82
15
52
334
334
294
420
362
362
314
114
150
150
425
1,120
1,581
1,581
1,846
2,395
2,420
2,420
265
102
600
600
474
1,649
1,196
1,196
1,399
1,466
1,705
1,705
2,183
2,096
5,809
5,809
3,127
1,345
1,992
1,910
4,715
1,477
3,614
3,614
2,571
3,673
2,867
4,517
4,517
3,563
5
6,199
6,245
5,278
5,057
6,199
5,041
2,183
839
1,009
1,009
793
516
1,566
1,566
938
1,129
2,532
2,505
2,187
1,379
2,119
1,434
1,175
1,461
1,564
1,976
1,446
690
1,848
984
824
602
3,587
2,031
2,0313,5876028249841,8486901,4461,9761,5641,4611,1751,4342,1191,3792,1872,5052,5321,1299381,5661,5665167931,0091,0098392,1835,0416,1995,0575,2786,2456,19953,5634,5174,5172,8673,6732,5713,6143,6141,4774,7151,9101,9921,3453,1275,8095,8092,0962,1831,7051,7051,4661,3991,1961,1961,6494746006001022652,4202,4202,3951,8461,5811,5811,12042515015011431436236242029433433452158282113179398398349344344295297345345500500580580570500530700700680600600590380
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
100
100
200
45
45
22
73
177
177
119
178
178
106
20
20
0
0
0
0
0
0
0
0
0
0
0
0
191
191
645
1,079
1,079
1,270
1,427
76
76
44
0
461
461
37
34
76
76
56
7
70
70
43
7
104
104
63
7
99
58
3,426
233
369
369
347
1,174
151
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
145
117
89
111
114
225
120
181
244
101
104
107
339
205
116
744
514
346
174
501
413
413501174346514744116205339107104101244181120225114111891171450000000000000001001001511,1743473693692333,426589976310410474370707567676343746146104476761,4271,2701,0791,07964519119100000000000020201061781781191771777322454520010010000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
347
0
0
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
145
0
0
0
0
108
31
120
214
0
0
0
229
92
0
624
514
346
174
501
413
41350117434651462409222900021412031108000014500000000000000001000003470000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
320
320
0
0
0
340
290
310
0
310
300
300
211
211
201
141
0
87
151
141
41
41
71
74
13
12
43
292
237
237
284
319
270
270
67
95
152
152
327
361
392
392
466
27
64
64
27
79
196
196
520
694
499
499
1,076
724
889
889
782
650
1,817
543
479
808
977
970
921
669
1,269
411
1,652
425
1,184
1,184
521
1
5,973
2,121
1,521
1,393
728
1,405
434
579
975
612
203
392
1,566
750
449
226
1,661
1,806
1,555
1,053
758
997
792
776
860
1,287
919
265
448
172
206
135
2,073
1,081
1,0812,0731352061724482659191,2878607767929977581,0531,5551,8061,6612264497501,5663922036129755794341,4057281,3931,5212,1215,97315211,1841,1844251,6524111,2696699219709778084795431,8176507828898897241,0764994996945201961967927646427466392392361327152152956727027031928423723729243121374714141141151870141201211211300300310031029034000032032000
       Other Current Liabilities 
380
590
280
280
680
700
0
190
210
260
0
270
200
0
89
89
95
81
0
79
79
79
32
32
23
7
2
2
9
42
57
56
137
42
44
44
47
55
82
82
149
141
184
184
40
2,317
157
103
75
61
241
242
1,095
427
844
844
382
911
1,251
1,251
1,307
3,917
1,247
1,247
629
876
690
319
270
1,083
955
1,688
717
2,161
3,233
572
3,041
4
226
4,124
3,756
3,664
5,472
3,636
1,749
259
34
397
590
124
0
816
372
814
760
585
407
206
1,180
192
282
581
597
350
321
308
656
298
617
467
1,012
536
5361,0124676172986563083213505975812821921,1802064075857608143728160124590397342591,7493,6365,4723,6643,7564,12422643,0415723,2332,1617171,6889551,0832703196908766291,2471,2473,9171,3071,2511,2519113828448444271,09524224161751031572,31740184184141149828255474444421375657429227233232797979081958989020027002602101900700680280280590380
   > Long-term Liabilities 
10
10
10
320
0
0
0
100
50
50
50
50
100
100
256
256
201
214
0
265
270
319
0
147
91
74
0
12
43
292
0
237
284
319
0
270
117
179
179
343
971
0
0
1,662
203
39
39
540
1,644
1,192
1,192
228
3
3
3
3
1,084
2,042
2,042
4,464
6,178
953
953
1,361
2,254
2,652
3,049
44
33
22
22
7,973
7,962
7,962
7,962
7,962
7,962
7,960
0
7,962
7,962
7,962
728
1,405
434
579
0
612
203
392
0
750
106
108
60
31
137
214
124
31
239
212
184
155
126
95
64
10
0
0
0
0
0000106495126155184212239311242141373160108106750039220361205794341,4057287,9627,9627,96207,9607,9627,9627,9627,9627,9627,973222233443,0492,6522,2541,3619539536,1784,4642,0422,0421,08433332281,1921,1921,64454039392031,66200971343179179117270031928423702924312074911470319270265021420125625610010050505050100000320101010
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137
214
124
31
0
0
0
0
0
0
0
0
0
0
0
0
00000000000031124214137000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77
66
55
44
33
21
11
0
0
0
7,962
0
0
7,962
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000007,962007,962000112133445566770000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,962
7,962
7,962
7,962
7,962
7,962
7,962
0
0
7,962
7,962
7,962
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000007,9627,9627,962007,9627,9627,9627,9627,9627,9627,9620000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
240
-290
-280
-280
-340
-450
0
350
-60
-130
0
-100
-100
-200
5,854
5,854
5,256
4,917
0
4,498
3,876
3,394
3,097
3,097
1,670
1,236
900
900
1,114
1,152
754
754
365
1,448
948
948
1,237
594
186
186
-262
17
0
-23
-1,698
-458
9,752
9,752
8,987
6,603
3,101
3,101
6,590
3,829
2,127
2,127
1,628
-893
0
-3,725
-3,726
-871
-346
-346
-58
-1,601
-1,778
1,130
2,853
30,301
82,885
82,885
77,587
75,364
70,429
70,429
63,930
60
17,141
55,333
50,894
46,693
17,141
14,113
11,266
10,164
8,882
8,882
6,233
4,938
11,772
11,772
8,620
6,537
3,772
3,419
3,029
7,404
4,626
3,096
1,471
7,239
4,245
1,606
6,784
3,954
1,493
14,278
13,222
11,287
8,098
12,430
12,4308,09811,28713,22214,2781,4933,9546,7841,6064,2457,2391,4713,0964,6267,4043,0293,4193,7726,5378,62011,77211,7724,9386,2338,8828,88210,16411,26614,11317,14146,69350,89455,33317,1416063,93070,42970,42975,36477,58782,88582,88530,3012,8531,130-1,778-1,601-58-346-346-871-3,726-3,7250-8931,6282,1272,1273,8296,5903,1013,1016,6038,9879,7529,752-458-1,698-23017-2621861865941,2379489481,4483657547541,1521,1149009001,2361,6703,0973,0973,3943,8764,49804,9175,2565,8545,854-200-100-1000-130-603500-450-340-280-280-290240
   Common Stock
390
390
430
430
460
470
0
510
510
510
0
550
700
700
809
809
874
882
0
845
878
878
886
886
886
888
888
888
961
1,004
1,138
1,138
1,161
1,255
1,257
1,257
1,324
1,341
1,366
1,366
1,384
1,391
1,399
1,399
1,407
1,422
1,464
1,464
16
18
24
24
2
2
2
2
2
2
2
2
2
3
3
3
3
3
0
0
1
1
3
3
3
3
3
3
3
0
3
3
3
3
3
3
3
3
0
0
0
0
0
0
1
1
1
1
1
1
1
1
3
3
3
3
3
3
5
2
2
2
0
0
002225333333111111110000003333333303333333110033333222222222242418161,4641,4641,4221,4071,3991,3991,3911,3841,3661,3661,3411,3241,2571,2571,2551,1611,1381,1381,004961888888888886886886878878845088287480980970070055005105105100470460430430390390
   Retained Earnings -301,052-297,253-294,027-292,055-290,949-289,542-286,993-284,077-281,216-278,494-275,284-271,485-269,768-246,020-243,190-240,970-238,823-236,168-233,377-231,153-227,802-227,802-218,081-216,551-213,499-213,499-212,156-210,921-207,935-204,660-175,012-170,739-166,097-204,660-161-157,227-150,668-150,668-145,681-142,812-136,586-126,172-126,172-122,821-119,289-117,044-115,185-112,772-107,628-105,013-105,013-97,715-91,916-89,066-89,066-86,522-81,468-78,700-78,700-75,946-70,960-54,258-54,258-45,902-37,741-35,305-35,305-32,979-31,020-29,987-29,987-29,096-27,689-26,773-26,773-25,912-23,623-22,912-22,912-22,023-20,950-20,426-20,426-19,613-18,701-18,365-18,365-17,901-16,473-14,506-14,506-14,025-12,986-12,986-12,482-12,075-11,313-11,313-11,000-10,800-10,400-10,400-10,190-10,030-9,570-9,030-9,030-8,880-8,290-8,290-7,730-7,390
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
93,165
93,987
104,139
107,279
110,573
112,711
113,581
115,266
120,419
125,673
156,471
219,468
220,358
220,439
220,988
221,067
221,112
221,171
0
221,816
221,417
221,541
221,653
221,816
222,058
222,194
222,323
222,397
222,707
222,800
223,029
239,572
239,729
239,771
239,911
239,940
242,242
243,996
250,592
250,644
272,863
272,954
0
0
0
0
0
0
0
0
0
0
0
00000000000272,954272,863250,644250,592243,996242,242239,940239,911239,771239,729239,572223,029222,800222,707222,397222,323222,194222,058221,816221,653221,541221,417221,8160221,171221,112221,067220,988220,439220,358219,468156,471125,673120,419115,266113,581112,711110,573107,279104,13993,98793,16500000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
7,240
7,050
7,580
7,580
8,080
8,110
0
9,410
9,460
9,550
0
9,710
11,200
11,300
14,423
14,423
16,618
16,873
0
16,545
17,095
17,095
0
18,826
18,826
18,855
0
18,928
19,981
20,622
0
20,709
21,393
23,242
0
23,283
25,879
26,051
0
26,525
27,877
29,040
0
30,130
30,422
34,004
0
46,560
55,505
63,151
0
74,704
83,231
83,248
0
84,280
88,912
88,983
0
89,015
94,894
101,166
0
108,233
113,257
114,580
116,095
121,269
126,545
157,364
0
220,300
220,439
220,988
221,067
221,067
221,171
221
-19
221,417
221,541
221,653
221,816
222,058
222,194
222,323
-16
222,397
222,800
223,029
1
239,572
239,771
239,911
239,940
242,242
243,996
250,592
250,644
272,863
272,954
282,520
282,736
282,819
290,858
290,944
291,030
305,224
305,274
305,311
305,351
313,481
313,481305,351305,311305,274305,224291,030290,944290,858282,819282,736282,520272,954272,863250,644250,592243,996242,242239,940239,911239,771239,5721223,029222,800222,397-16222,323222,194222,058221,816221,653221,541221,417-19221221,171221,067221,067220,988220,439220,3000157,364126,545121,269116,095114,580113,257108,2330101,16694,89489,015088,98388,91284,280083,24883,23174,704063,15155,50546,560034,00430,42230,130029,04027,87726,525026,05125,87923,283023,24221,39320,709020,62219,98118,928018,85518,82618,826017,09517,09516,545016,87316,61814,42314,42311,30011,2009,71009,5509,4609,41008,1108,0807,5807,5807,0507,240



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-8
Gross Profit-8-8
 
Operating Income (+$)
Gross Profit-8
Operating Expense-8,226
Operating Income-8,234-8,234
 
Operating Expense (+$)
Research Development3,229
Selling General Administrative5,005
Selling And Marketing Expenses8
Operating Expense8,2268,242
 
Net Interest Income (+$)
Interest Income0
Interest Expense-24
Other Finance Cost-369
Net Interest Income345
 
Pretax Income (+$)
Operating Income-8,234
Net Interest Income345
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,711-8,757
EBIT - interestExpense = -8,258
-7,711
-7,687
Interest Expense24
Earnings Before Interest and Taxes (EBIT)-8,234-7,687
Earnings Before Interest and Taxes (EBITDA)-8,226
 
After tax Income (+$)
Income Before Tax-7,711
Tax Provision-0
Net Income From Continuing Ops-7,034-7,711
Net Income-7,711
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses8,234
Total Other Income/Expenses Net523-345
 

Technical Analysis of Tenax Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tenax Therapeutics Inc. The general trend of Tenax Therapeutics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tenax Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tenax Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.44 < 3.6 < 3.6.

The bearish price targets are: 2.77 > 2.77.

Tweet this
Tenax Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tenax Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tenax Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tenax Therapeutics Inc. The current macd is -0.1160019.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tenax Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tenax Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tenax Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Tenax Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartTenax Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tenax Therapeutics Inc. The current adx is 28.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tenax Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Tenax Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tenax Therapeutics Inc. The current sar is 2.82532382.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Tenax Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tenax Therapeutics Inc. The current rsi is 47.23. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Tenax Therapeutics Inc Daily Relative Strength Index (RSI) ChartTenax Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tenax Therapeutics Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tenax Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Tenax Therapeutics Inc Daily Stochastic Oscillator ChartTenax Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tenax Therapeutics Inc. The current cci is -28.63831243.

Tenax Therapeutics Inc Daily Commodity Channel Index (CCI) ChartTenax Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tenax Therapeutics Inc. The current cmo is 3.13235617.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Tenax Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartTenax Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tenax Therapeutics Inc. The current willr is -25.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Tenax Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Tenax Therapeutics Inc Daily Williams %R ChartTenax Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tenax Therapeutics Inc.

Tenax Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tenax Therapeutics Inc. The current atr is 0.18161704.

Tenax Therapeutics Inc Daily Average True Range (ATR) ChartTenax Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tenax Therapeutics Inc. The current obv is 10,780,435.

Tenax Therapeutics Inc Daily On-Balance Volume (OBV) ChartTenax Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tenax Therapeutics Inc. The current mfi is 36.57.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tenax Therapeutics Inc Daily Money Flow Index (MFI) ChartTenax Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tenax Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Tenax Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tenax Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.227
Ma 20Greater thanMa 503.186
Ma 50Greater thanMa 1003.434
Ma 100Greater thanMa 2003.732
OpenGreater thanClose3.134
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tenax Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Tenax Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tenax Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tenax Therapeutics Inc

I send you an email if I find something interesting about Tenax Therapeutics Inc.


Stay informed about Tenax Therapeutics Inc.

Receive notifications about Tenax Therapeutics Inc in your mailbox!